Henriques Carina, Silva Marta, Silva António, Rufino-Ramos David, Lopes Miguel Monteiro, Badin Romina Aron, Hantraye Philippe, Pereira de Almeida Luís, Nobre Rui Jorge
Center for Neuroscience and Cell Biology (CNC), Gene and Stem Cell Therapies for the Brain Group, University of Coimbra, 3004-504 Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, 3004-504 Coimbra, Portugal; ViraVector-Viral Vector for Gene Transfer Core Facility, University of Coimbra, 3004-504 Coimbra, Portugal; Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; GeneT, Center for Excellence in Gene Therapy in Portugal, University of Coimbra, 3004-504 Coimbra, Portugal.
Center for Neuroscience and Cell Biology (CNC), Gene and Stem Cell Therapies for the Brain Group, University of Coimbra, 3004-504 Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), Vectors, Gene and Cell Therapy Group, University of Coimbra, 3004-504 Coimbra, Portugal; GeneT, Center for Excellence in Gene Therapy in Portugal, University of Coimbra, 3004-504 Coimbra, Portugal.
Exp Neurol. 2025 Nov;393:115413. doi: 10.1016/j.expneurol.2025.115413. Epub 2025 Aug 5.
Spinocerebellar ataxia type 3 (SCA3) is a devastating neurodegenerative disorder that belongs to the family of polyglutamine disorders. Although the CAG repeat expansion underlying SCA3 was discovered 30 years ago, there is still no cure or treatment able to delay its progression. One of the reasons for this lag may be attributed to the phenotypic and neuropathological heterogeneity among individuals. To overcome this gap, we aimed to delve into the specific contributions of hindbrain regions that have been consistently reported to be the most degenerated in SCA3 patients, the cerebellar cortex, namely lobules IV-V, VIII and IX, deep cerebellar nuclei and the pons. For this purpose, we used lentiviral vectors to deliver the SCA3-causing gene, mutant Ataxin-3, to these specific regions in mice. We observed that the overexpression of mutant Ataxin-3 in different hindbrain regions led to the formation of Ataxin-3 aggregates in neuronal cells and mild motor impairments. Neurons in the pons were more vulnerable to mutant Ataxin-3 overexpression than in the cerebellum. There was also an increase in astrocytes and microglia recruitment that may explain myelin damage and, consequently, white matter loss in the cerebellum. Indeed, cerebellar white matter loss was the most broadly observed pathological feature upon overexpression of mutant Ataxin-3 in different regions of the hindbrain. In conclusion, we confirm that cerebellar white matter changes are a consistent feature of SCA3 neuropathology, and demonstrate that the region-specific lentiviral models offer a valuable platform to study early, selective pathological mechanisms and support future therapeutic testing.
3型脊髓小脑共济失调(SCA3)是一种毁灭性的神经退行性疾病,属于多聚谷氨酰胺疾病家族。尽管30年前就发现了SCA3潜在的CAG重复扩增,但仍然没有能够延缓其进展的治愈方法或治疗手段。这种滞后的原因之一可能归因于个体之间的表型和神经病理学异质性。为了克服这一差距,我们旨在深入研究后脑区域的具体作用,这些区域一直被报道在SCA3患者中退化最为严重,即小脑皮质,也就是小叶IV-V、VIII和IX、小脑深部核团和脑桥。为此,我们使用慢病毒载体将导致SCA3的基因——突变型共济失调蛋白-3——传递到小鼠的这些特定区域。我们观察到,突变型共济失调蛋白-3在不同后脑区域的过表达导致神经元细胞中形成共济失调蛋白-3聚集体,并出现轻度运动障碍。脑桥中的神经元比小脑中的神经元更容易受到突变型共济失调蛋白-3过表达的影响。星形胶质细胞和小胶质细胞的募集也有所增加,这可能解释了髓鞘损伤以及随之而来的小脑白质损失。事实上,在不同后脑区域过表达突变型共济失调蛋白-3后,小脑白质损失是最广泛观察到的病理特征。总之,我们证实小脑白质变化是SCA3神经病理学的一个一致特征,并证明区域特异性慢病毒模型为研究早期、选择性病理机制提供了一个有价值的平台,并支持未来的治疗测试。